| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 443.58 KB | Adobe PDF |
Advisor(s)
Abstract(s)
In colon cancer distinct genetic subtypes have been described, one of which involves overexpression of RAC1b, a variant generated by alternative
splicing. Aberrant splicing is known to occur in cancer and can be caused by
mutation in a gene or splicing factor but also represents a dynamic response to
oncogene-induced cellular signaling and in this case it may be pharmacologically
targeted. Here we explore how signaling pathways are involved in the
deregulation of alternative RAC1b splicing in tumor cells.
Description
Keywords
RAC1b Colon Cancer Splicing Alternativo Vias de Transdução de Sinal e Patologias Associadas Cancro Coloretal
